Esther Cortes-Rivero

Cordoba, AN 14004, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomas.

Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomas.

Journal: Molecular biomedicine

Published: June 17, 2025

Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study.

Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study.

Journal: European journal of endocrinology

Published: September 28, 2023

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features.

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features.

Journal: Cancers

Published: August 02, 2019

Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas.

Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas.

Journal: Scientific reports

Published: July 24, 2017

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly.

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly.

Journal: Journal of cellular and molecular medicine

Published: June 16, 2017

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.

The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressiveness.

Journal: Molecular cancer

Published: November 01, 2016

Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.

Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.

Journal: The Journal of endocrinology

Published: August 26, 2016

Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker.

Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarker.

Journal: Cancer letters

Published: July 09, 2016

The Molecular Registry of Pituitary Adenomas (REMAH): A bet of Spanish Endocrinology for the future of individualized medicine and translational research.

The Molecular Registry of Pituitary Adenomas (REMAH): A bet of Spanish Endocrinology for the future of individualized medicine and translational research.

Journal: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

Published: October 06, 2015

BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.

BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.

Journal: Scientific reports

Published: May 29, 2015

In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters.

In1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parameters.

Journal: Oncotarget

Published: March 14, 2015

In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features.

In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features.

Journal: Scientific reports

Published: October 16, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026